Form 4: Stereotaxis Director Myriam Curet Granted Equity

Stereotaxis, Inc. Director Myriam Curet received a grant of 46,948 restricted share units, increasing her beneficial ownership to 392,058 shares.

Summary

• Myriam Curet, a Director of Stereotaxis, Inc. (STXS), was granted 46,948 restricted share units (RSUs) on January 2, 2026.
• Each restricted share unit represents the right to receive one share of common stock.
• The RSUs vest on the earliest of: the fifth anniversary of the award date (January 2, 2031), the date her service on the board terminates, or a Change of Control as defined in the award documents.
• Following this transaction, Myriam Curet beneficially owns a total of 392,058 shares of Stereotaxis, Inc. common stock.

Sentiment

Score: 7

Explanation: The grant of restricted share units to a director is a positive event for corporate governance, as it aligns the director's interests with shareholder value. It is a routine compensation event and not indicative of operational performance, hence a moderately positive score.

Positives

• The grant of restricted share units aligns the director's financial interests with those of the shareholders, incentivizing long-term value creation.
• The vesting schedule encourages continued service and commitment from the director to the company's strategic objectives.

Negatives

• The grant has no immediate cash value for the director, as it is subject to vesting conditions.
• The shares were acquired at a price of $0, which is typical for RSU grants but represents dilution potential if not managed carefully.

Risks

• The value of the restricted share units is subject to the future market price of Stereotaxis, Inc. common stock.
• The director risks forfeiture of the unvested RSUs if the vesting conditions (e.g., continued service) are not met.

Future Outlook

The vesting conditions for the restricted share units, particularly the five-year anniversary or termination of service, indicate an expectation of continued commitment and alignment of the director's interests with the company's long-term performance.

Industry Context

The grant of restricted share units to a director is a common practice in corporate governance across various industries, serving as a key component of non-executive director compensation to align their interests with long-term shareholder value.

Comparison to Industry Standards

• Equity compensation for directors, often in the form of restricted stock or RSUs, is a standard practice among publicly traded companies, particularly in the medical technology sector where long-term strategic vision is crucial.
• The vesting schedule, tied to continued service or a change of control, is typical for such awards, aiming to retain talent and incentivize sustained performance.

Related Party Transactions

• Myriam Curet, a Director of Stereotaxis, Inc., received a grant of 46,948 restricted share units, which is a form of compensation from the company to a related party.

Stakeholder Impact

• Shareholders: The grant aligns the director's long-term interests with shareholder value, potentially leading to more focused decision-making aimed at increasing stock price.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The restricted share units will vest according to the specified conditions, which include the fifth anniversary of the award date (January 2, 2031), termination of director service, or a Change of Control.

Key Dates

Keywords

Stereotaxis, STXS, Myriam Curet, Form 4, SEC filing, restricted stock units, RSU grant, director compensation, equity award, beneficial ownership